CD20-negative De Novo Diffuse Large B-Cell Lymphoma in HIV-negative Patients: A Matched Case-Control Analysis in a Single Institution

Journal of Translational Medicine - United Kingdom
doi 10.1186/1479-5876-10-84
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Molecular Analysis of a CD19-negative Diffuse Large B-Cell Lymphoma

Haematologica
Hematology
2018English

Diffuse Large B-Cell Lymphoma: A Case Report

Clinical and Experimental Health Sciences
2018English

The Negative Prognostic Significance of Serum Immunoglobulin Paraprotein in Patients With Diffuse Large B Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Follicular Lymphoma With Progression to Diffuse Large B-Cell Lymphoma and Concurrent CD5-Negative Mantle Cell Lymphoma-3 Entities in a Lymph Node

Cancer Control
MedicineOncologyHematology
2014English

miR‑150 Is a Negative Independent Prognostic Biomarker for Primary Gastrointestinal Diffuse Large B‑cell Lymphoma

Oncology Letters
Cancer ResearchOncology
2020English

Primary Cutaneous Diffuse Large B-Cell Lymphoma – A Case Report

Serbian Journal of Dermatology and Venereology
Dermatology
2017English

Response of Diffuse Large B-Cell Lymphoma Treated With R-Chop and Prognostic Factors Associated: A Single Institution Analysis in Lima, Peru

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Diffuse Large B-Cell Lymphoma

2020English

3A Comparison Between R-THP-Cop and R-Chop Regimens for the Treatment of Diffuse Large B-Cell Lymphoma in Old Patients: A Single-Institution Analysis

Internal Medicine
Internal MedicineMedicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy